Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ART27.13 / Artelo Biosci, adMare BioInnovations
2020-000464-27: A Phase 1/2 clinical trial of ART27.13 in patients with a lack or loss of appetite and weight loss due to having cancer.	Ongoing	1/2	49	Europe	ART27.13 200µg, ART27.13 50µg, Capsule, hard	Artelo Biosciences Limited, Artelo Biosciences Limited	Cancer anorexia and weight loss, Lack or loss of appetite and weight loss associated with cancer., Diseases [C] - Cancer [C04]
cannabidiol/tetramethylpyrazine cocrystal (ART12.11) / Artelo Biosci
No trials found
ART26.12 / Artelo Biosci
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ART27.13 / Artelo Biosci, adMare BioInnovations
2020-000464-27: A Phase 1/2 clinical trial of ART27.13 in patients with a lack or loss of appetite and weight loss due to having cancer.	Ongoing	1/2	49	Europe	ART27.13 200µg, ART27.13 50µg, Capsule, hard	Artelo Biosciences Limited, Artelo Biosciences Limited	Cancer anorexia and weight loss, Lack or loss of appetite and weight loss associated with cancer., Diseases [C] - Cancer [C04]
cannabidiol/tetramethylpyrazine cocrystal (ART12.11) / Artelo Biosci
No trials found
ART26.12 / Artelo Biosci
No trials found